India to Brazil: Bevacizumab Export Trade Route
India has recorded 49 verified shipments of Bevacizumab exported to Brazil, representing a combined trade value of $505.0K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $10.3K USD. The leading Indian exporter is BIOCON BIOLOGICS INDIA LIMITED, which accounts for 87% of total export value with 4 shipments worth $437.0K USD. On the buying side, XXOCOXXBIOXXGICXXUK XXMITXX is the largest importer in Brazil with $218.7K USD in purchases. The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED, VAMA LIFECARE PRIVATE LIMITED — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Bevacizumab corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $505.0K USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $10.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 24.8%, placing it at rank #13 among India's top bevacizumab export destinations globally.
On the import side, key buyers of Indian bevacizumab in Brazil include XXOCOXXBIOXXGICXXUK XXMITXX, BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF and 23 others. XXOCOXXBIOXXGICXXUK XXMITXX is the single largest importer with 2 shipments valued at $218.7K USD.
Route Characteristics
- Average transit
